Primary pure large cell neuroendocrine carcinoma of the ovary: A rare case report and review of literature

4Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Ovarian large cell neuroendocrine carcinoma (LCNEC), or ovarian non-small cell neuroendocrine carcinoma, which is a newly described tumour in the classification of primary ovarian neoplasms by the World Health Organization, is a rare entity that is frequently associated with a surface epithelial and germ cell neoplasm component. Few cases have been reported in the literature, and only 18 primary pure ovarian LCNEC cases have been reported so far, including our 1 case. Ovarian LCNEC is a highly aggressive tumor with a poor prognosis even at an early stage.Patient concerns: We report a case of a 55-year-old postmenopausal woman who complained of abdominal pain. CT examination revealed a mass in the right adnexial region and CA125 level was elevated.Diagnosis: She underwent a exploratory laparotomy, and diagnosed as LCNEC histopathologically.Interventions: Cytoreductive surgery was administered to the patient, and had accepted 5 cycles of chemotherapy consisting of paclitaxel and cisplatin.Outcomes: Follow-up for 12 months showed no clinical or radiological evidence of disease recurrence. Conclusion: This case is 1 of the ovarian LCNEC which is a rare and extremely malignant tumor. Diagnosis requires histopathology and immunohistochemistry. The treatment includes primary cytoreductive surgery followed by chemotherapy.

Cite

CITATION STYLE

APA

Peng, X., & Wang, H. (2020). Primary pure large cell neuroendocrine carcinoma of the ovary: A rare case report and review of literature. Medicine (United States), 99(49). https://doi.org/10.1097/MD.0000000000022474

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free